StonvexLoading…
StonvexStonvexStonvexCore line items from SLND's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $772.17M | $980.18M | $1.16B | $1.16B |
Operating Income | $-216.88M | $-126.31M | $-31.38M | $82.70M |
Net Income | $-306.54M | $-105.36M | $-19.25M | $60.54M |
EPS (Diluted) | $-5.67 | $-2.19 | $-0.41 | Not available |
Total Assets | $989.28M | $1.20B | $1.20B | $1.13B |
Total Liabilities | $1.12B | $1.03B | $940.50M | $765.42M |
Cash & Equivalents | $52.71M | $72.19M | $49.18M | $57.91M |
Free Cash Flow OCF − CapEx | $12.73M | $-5.49M | $-21.11M | $-70.97M |
Shares Outstanding | 54.11M | 53.94M | 47.89M | 0 |